An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer
- M. J. Drake
- , W. Robson
- , P. Mehta
- , I. Schofield
- , D. E. Neal
- , H. Y. Leung
Research output: Contribution to journal › Article › peer-review
92
Link opens in a new tab
Scopus
citations